source
- Jazz CEO urges industry to boost gender diversity in biopharma leadershipRenee Gala, the newly appointed chief executive of Jazz, said her own sponsors took chances on her and urged the biopharma sector to do the same to revive momentum for gender equity in leadership.…
- Biomea posts modest Phase 1 results for oral GLP-1 drug, shares slideBiomea Fusion released Phase 1 data for its oral small‑molecule GLP‑1 agonist BMF‑650, positioning the program as a potential partner opportunity that could separate efficacy from gastrointestinal…